Boill Healthcare Holdings Limited

SEHK:1246 Stock Report

Market Cap: HK$407.4m

Boill Healthcare Holdings Past Earnings Performance

Past criteria checks 0/6

Boill Healthcare Holdings has been growing earnings at an average annual rate of 9.7%, while the Real Estate industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 7.4% per year.

Key information

9.7%

Earnings growth rate

20.9%

EPS growth rate

Real Estate Industry Growth2.8%
Revenue growth rate7.4%
Return on equity-351.2%
Net Margin-57.3%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Apr 18
The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Feb 05
Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Jul 31
Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

Apr 18
Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Jul 22
There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Jul 13
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Mar 21
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Jan 27
Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Dec 05
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Revenue & Expenses Breakdown
Beta

How Boill Healthcare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:1246 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23355-203370
30 Jun 23352-213330
31 Mar 23348-224300
30 Sep 22430-30240
30 Jun 22717-21360
31 Mar 221,005-12470
31 Dec 211,028-299840
30 Sep 211,039-81890
30 Jun 21628-112860
31 Mar 21217-142840
31 Dec 20139-172760
30 Sep 2061-201680
30 Jun 2084-195630
31 Mar 20106-189570
31 Dec 19227-185590
30 Sep 19347-181610
30 Jun 19384-190770
31 Mar 19420-200930
31 Dec 18572-2321050
30 Sep 18724-2371180
30 Jun 18731-2251230
31 Mar 18738-2141280
31 Dec 17616-2981220
30 Sep 17459-412980
30 Jun 17473-491940
31 Mar 17487-570890
31 Dec 16492-4501020
30 Sep 16485-3271100
30 Jun 16509-260990
31 Mar 16532-193870
31 Dec 15512-113800
30 Sep 15492-33720
30 Jun 1552529670
31 Mar 1555891610
31 Dec 1456284560
30 Sep 1456678500
30 Jun 1452776490
31 Mar 1448773470
31 Dec 1344169370
30 Sep 1339564260
30 Jun 1337563240

Quality Earnings: 1246 is currently unprofitable.

Growing Profit Margin: 1246 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1246 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.7% per year.

Accelerating Growth: Unable to compare 1246's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1246 is unprofitable, making it difficult to compare its past year earnings growth to the Real Estate industry (-2.9%).


Return on Equity

High ROE: 1246 has a negative Return on Equity (-351.21%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.